Clinical trial
Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT)
NCT05035316 is registered in ClinicalTrials.gov with Lars Vedel Kessing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT)
- Lead sponsor
- Lars Vedel Kessing
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 20, 2022
- Completion date
- November 18, 2024
- Enrollment
- 250 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.